Organon & Co. Statistics
Total Valuation
Organon & Co. has a market cap or net worth of $5.28 billion. The enterprise value is $13.48 billion.
Market Cap | 5.28B |
Enterprise Value | 13.48B |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, before market open.
Earnings Date | Aug 6, 2024 |
Ex-Dividend Date | May 10, 2024 |
Share Statistics
Organon & Co. has 257.17 million shares outstanding. The number of shares has increased by 0.86% in one year.
Shares Outstanding | 257.17M |
Shares Change (YoY) | +0.86% |
Shares Change (QoQ) | +0.69% |
Owned by Insiders (%) | 0.16% |
Owned by Institutions (%) | 79.54% |
Float | 256.39M |
Valuation Ratios
The trailing PE ratio is 5.07 and the forward PE ratio is 4.55.
PE Ratio | 5.07 |
Forward PE | 4.55 |
PS Ratio | 0.84 |
Forward PS | 0.82 |
PB Ratio | 111.17 |
P/FCF Ratio | 10.44 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.33, with an EV/FCF ratio of 26.37.
EV / Earnings | 12.87 |
EV / Sales | 2.12 |
EV / EBITDA | 9.33 |
EV / EBIT | 11.23 |
EV / FCF | 26.37 |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 181.54.
Current Ratio | 1.65 |
Quick Ratio | 0.83 |
Debt / Equity | 181.54 |
Debt / EBITDA | 6.03 |
Debt / FCF | 17.05 |
Interest Coverage | 2.28 |
Financial Efficiency
Return on equity (ROE) is -359.20% and return on invested capital (ROIC) is 21.97%.
Return on Equity (ROE) | -359.20% |
Return on Assets (ROA) | 9.10% |
Return on Capital (ROIC) | 21.97% |
Revenue Per Employee | $634,700 |
Profits Per Employee | $104,700 |
Employee Count | 10,000 |
Asset Turnover | 0.55 |
Inventory Turnover | 2.18 |
Taxes
Income Tax | -373.00M |
Effective Tax Rate | -55.34% |
Stock Price Statistics
The stock price has decreased by -0.20% in the last 52 weeks. The beta is 0.82, so Organon & Co.'s price volatility has been lower than the market average.
Beta (1Y) | 0.82 |
52-Week Price Change | -0.20% |
50-Day Moving Average | 19.68 |
200-Day Moving Average | 17.00 |
Relative Strength Index (RSI) | 46.63 |
Average Volume (30 Days) | 2,026,788 |
Short Selling Information
The latest short interest is 8.11 million, so 3.15% of the outstanding shares have been sold short.
Short Interest | 8.11M |
Short Previous Month | 10.94M |
Short % of Shares Out | 3.15% |
Short % of Float | 3.16% |
Short Ratio (days to cover) | 3.37 |
Income Statement
In the last 12 months, Organon & Co. had revenue of $6.35 billion and earned $1.05 billion in profits. Earnings per share was $4.09.
Revenue | 6.35B |
Gross Profit | 3.75B |
Operating Income | 1.24B |
Pretax Income | 674.00M |
Net Income | 1.05B |
EBITDA | 1.44B |
EBIT | 1.20B |
Earnings Per Share (EPS) | $4.09 |
Balance Sheet
The company has $575.00 million in cash and $8.71 billion in debt, giving a net cash position of -$8.14 billion or -$31.65 per share.
Cash & Cash Equivalents | 575.00M |
Total Debt | 8.71B |
Net Cash | -8.14B |
Net Cash Per Share | -$31.65 |
Equity / Book Value | 48.00M |
Book Value Per Share | 0.19 |
Working Capital | 1.65B |
Cash Flow
In the last 12 months, operating cash flow was $761.00 million and capital expenditures -$250.00 million, giving a free cash flow of $511.00 million.
Operating Cash Flow | 761.00M |
Capital Expenditures | -250.00M |
Free Cash Flow | 511.00M |
FCF Per Share | $2.00 |
Margins
Gross margin is 59.04%, with operating and profit margins of 19.52% and 16.50%.
Gross Margin | 59.04% |
Operating Margin | 19.52% |
Pretax Margin | 10.62% |
Profit Margin | 16.50% |
EBITDA Margin | 22.75% |
EBIT Margin | 18.91% |
FCF Margin | 8.05% |
Dividends & Yields
This stock pays an annual dividend of $1.12, which amounts to a dividend yield of 5.47%.
Dividend Per Share | $1.12 |
Dividend Yield | 5.47% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 27.38% |
Buyback Yield | -0.86% |
Shareholder Yield | 4.54% |
Earnings Yield | 19.62% |
FCF Yield | 9.58% |
Analyst Forecast
The average price target for Organon & Co. is $23.50, which is 14.69% higher than the current price. The consensus rating is "Buy".
Price Target | $23.50 |
Price Target Difference | 14.69% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | -0.04% |
EPS Growth Forecast (5Y) | 0.75% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Organon & Co. has an Altman Z-Score of 1.37 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.37 |
Piotroski F-Score | 4 |